1. Inhibition of Ceramide Glycosylation Enhances Cisplatin Sensitivity in Cholangiocarcinoma by Limiting the Activation of the ERK Signaling Pathway
   Piyasiri Chueakwon et al, 2022, Life CrossRef
2. RNF43 overexpression attenuates the Wnt/β‑catenin signalling pathway to suppress tumour progression in cholangiocarcinoma
   Norma Pangestu et al, 2021, Oncology Letters CrossRef
3. The Role of Herbal Medicine in Cholangiocarcinoma Control: A Systematic Review
   Kesara Na-Bangchang et al, 2023, Planta Medica CrossRef
4. Clinical Significance of Heme Oxygenase 1 in Tumor Progression
   Mariapaola Nitti et al, 2021, Antioxidants CrossRef
5. Enzymatic synthesis of phenolic acid glucosyl esters to test activities on cholangiocarcinoma cells
   Eko Suyanto et al, 2024, Applied Microbiology and Biotechnology CrossRef
6. Down-Regulation of C1GALT1 Enhances the Progression of Cholangiocarcinoma through Activation of AKT/ERK Signaling Pathways
   Juthamas Khiaowichit et al, 2022, Life CrossRef
7. Piperlongumine inhibits antioxidant enzymes, increases ROS levels, induces DNA damage and G2/M cell cycle arrest in breast cell lines
   Adrivanio Baranoski et al, 2024, Journal of Toxicology and Environmental Health, Part A CrossRef
8. Altered O-linked glycosylation in benign and malignant meningiomas
   Chutima Talabnin et al, 2024, PeerJ CrossRef